What Is a Vector?
In genetic medicine, a vector is the delivery system. The therapy may be the genetic payload, but the payload has to reach the right cells before it can do anything useful. Some vectors are engineered from viruses because viruses naturally know how to enter cells. Other delivery systems use lipid nanoparticles or nonviral platforms.
Plain-English explanation
In genetic medicine, a vector is the delivery system. The therapy may be the genetic payload, but the payload has to reach the right cells before it can do anything useful. Some vectors are engineered from viruses because viruses naturally know how to enter cells. Other delivery systems use lipid nanoparticles or nonviral platforms.
Why it matters
Delivery is one of the hardest problems in genetic medicine. A therapy can be beautifully designed and still fail if it cannot reach the right tissue, enters too few cells, triggers an immune response, or cannot carry a large enough payload. For families, the vector often shapes who can receive a treatment and what risks must be monitored.
How it works
Scientists choose or engineer a vector based on where the therapy needs to go. AAV vectors are common in gene therapy because they can deliver genetic material to certain tissues, but they have size limits and immune considerations. Researchers study biodistribution, dose, pre-existing antibodies, manufacturing consistency, and whether the vector reaches the cells that matter for the disease.
Key terms
Related interviews and articles
Dr. Guoping Feng (MIT) on SHANK3 Gene Therapy, Brain Disorders, and What’s Coming Next
Dr. Guoping Feng
Welcome — I’m Ron Kleiman, and this is GENEration Hope. In this episode, I’m joined by Dr. Guoping Feng, Professor of Neuroscience at MIT, affiliated with the McGovern Institute, the Yang Tan Collective, and the Broad Institute. 
Dr. Curtis Rogers on Phelan-McDermid: Diagnosis, Newborn Screening, AI & Gene Therapy Delivery
Dr. Curtis Rogers
Dr. Curtis Rogers is a Senior Clinical Geneticist at the Greenwood Genetic Center and a long-time leader in the Phelan-McDermid syndrome (PMS) community. In this wide-ranging conversation recorded at the 2024 Phelan-McDermid community co...